Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity
T. Mclaughlin et al., Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity, METABOLISM, 50(7), 2001, pp. 819-824
The relationship between insulin-mediated glucose disposal and daylong free
fatty acid (FFA) concentrations before and after sibutramine-assisted weig
ht loss was investigated in 24 healthy, normotensive, nondiabetic, obese wo
men (body mass index [BMI] > 30.0 kg/m(2)). The 24 volunteers were defined
as being insulin-resistant (IR) or insulin-sensitive (IS) on the basis of t
heir steady-state plasma glucose (SSPG] concentration in response to a 180-
minute continuous intravenous infusion of octreotide, insulin, and glucose.
The mean (a SEM) SSPG concentrations were significantly higher (P < .001)
in the IR group (219 +/- 7 v 69 +/- 6 mg/dL) at baseline. The IR group also
had significantly higher plasma glucose (P =.002), insulin (P < .001), and
FFA (P =.02) concentrations measured at hourly intervals from 8 AM to 4 PM
, before and after breakfast (8 AM) and lunch (noon). Weight loss in respon
se to an energy-restricted diet for 4 months and sibutramine (15 mg/d) was
comparable in the 2 experimental groups (8.6 +/- 1.3 v 7.9 +/- 1.4 kg). SSP
G concentrations decreased significantly (P < .001) following weight loss (
219 +/- 7 to 144 +/- mg/dL) in the IR group, but there was no change in the
SSPG of the IS group (69 +/- 6 to 73 +/- 7 mg/dL, The improvement in insul
in sensitivity in the IR group after weight loss was associated with a sign
ificant decline in daylong plasma glucose (P > .001) and insulin (P =.02) c
oncentrations, without a weight-loss-associeted decrease in daylong plasma
FFA responses. In contrast, there was no significant change in plasma gluco
se, insulin, and FFA concentrations following weight loss in the IS group.
These results indicate that daylong FFA concentrations vary substantially i
n obese individuals as a function of whether they are IR or IS. Furthermore
the observation that the IR group was more insulin-sensitive after weight
loss, associated with lower daylong insulin concentrations in the absence o
f a significant decrease in circulating FFA concentrations, suggests that r
esistance to insulin-mediated glucose disposal in obese individuals cannot
be entirely due to high FFA levels, Copyright (C) 2001 by W.B. Saunders Com
pany.